Skip to main content

The impact of cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) on the incidence of alopecia in patients with metastatic breast cancer (BC).

Authors : Eiger D, Wagner M, Pondé NF, Nogueira MS, Buisseret L, de Azambuja E
Year : 2020
Journal : Acta oncol (Stockholm)
Volume : 59
Pages : 723-725